| Field | Row 1 |
|---|---|
| adsh | 0001437749-25-016431 |
| cik | 914139 |
| name | PARKERVISION INC |
| sic | 3663 |
| countryba | US |
| stprba | FL |
| cityba | JACKSONVILLE |
| zipba | 32207 |
| bas1 | 4446 - 1A HENDRICKS AVENUE |
| bas2 | SUITE 354 |
| baph | 9047326100 |
| countryma | US |
| stprma | FL |
| cityma | JACKSONVILLE |
| zipma | 32207 |
| mas1 | 4446 - 1A HENDRICKS AVENUE |
| mas2 | SUITE 354 |
| countryinc | US |
| stprinc | FL |
| ein | 592971472 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-13 16:04:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | prkr20250331_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001437749-25-016431 | 20241231 | Accounts Payable Current | 507000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Cash And Cash Equivalents At Carrying Value | 4918000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 1734000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Common Stock Shares Authorized | 225000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Common Stock Shares Outstanding | 117519000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Common Stock Value | 1175000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Cost Of Revenue | 59000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Gross Profit | -59000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Gross Profit | -54000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -13000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Interest And Other Income | 32000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20250331 | Interest Expense Nonoperating | 73000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Liabilities Current | 2949000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Long Term Notes Payable | 166000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Net Cash Provided By Used In Financing Activities | -33000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Net Cash Provided By Used In Operating Activities | -1827000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Other Assets Noncurrent | 1000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Paid In Kind Interest | 68000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Proceeds From Warrant And Stock Option Exercised | 262000.0000 | USD | 1 | 0001437749-25-016431 | |||
| 0001437749-25-016431 | 20240331 | Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights | 0.0000 | USD | 1 | 0001437749-25-016431 | |||
| 0001437749-25-016431 | 20240331 | Repayments Of Long Term Debt | 33000.0000 | USD | 1 | us-gaap/2025 | Longterm Debt Type= Notes Payable Other Payables; | ||
| 0001437749-25-016431 | 20250331 | Share Based Compensation | 122000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Shares Outstanding | 113970000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20241231 | Stockholders Equity | 400630000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20241231 | Stockholders Equity | -448182000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 0.0000 | USD | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | 14000.0000 | USD | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Issued For Services | 1000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Issued For Services | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | 29000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 115831000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Net Income Loss | -693000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20241231 | Accrued Salaries Current | 709000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Assets | 4349000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Assets Current | 5045000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -220000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001437749-25-016431 | 20250331 | Common Stock Shares Authorized | 225000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Comprehensive Income Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Cost Of Revenue | 54000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Earnings Per Share Basic | -0.0300 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Gain Loss Contingent Payment Obligation | 2461000.0000 | USD | 1 | 0001437749-25-016431 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 129000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Interest Expense Nonoperating | 104000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Notes Payable Current | 139000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001437749-25-016431 | 20250331 | Operating Expenses | 1243000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Prepaid Expense Current | 93000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Proceeds From Warrant And Stock Option Exercised | 0.0000 | USD | 1 | 0001437749-25-016431 | |||
| 0001437749-25-016431 | 20240331 | Share Based Compensation | 72000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20231231 | Stockholders Equity | -39519000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Stockholders Equity | 393496000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20240331 | Stockholders Equity | 884000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | 224000.0000 | USD | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20250331 | Assets Current | 3536000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1638000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Comprehensive Income Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20241231 | Convertible Debt Current | 500000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001437749-25-016431 | 20241231 | Convertible Debt Noncurrent | 2798000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001437749-25-016431 | 20240331 | Gain Loss Contingent Payment Obligation | 220000.0000 | USD | 1 | 0001437749-25-016431 | |||
| 0001437749-25-016431 | 20250331 | Gain Loss Contingent Payment Obligation | -2461000.0000 | USD | 1 | 0001437749-25-016431 | |||
| 0001437749-25-016431 | 20240331 | Gross Profit | -59000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants | 241000.0000 | USD | 1 | 0001437749-25-016431 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Shares | 0.0000 | shares | 1 | 0001437749-25-016431 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Liabilities | 53943000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Long Term Notes Payable | 201000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Net Cash Provided By Used In Financing Activities | 223000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Net Income Loss | -693000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Net Income Loss | -3799000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20250331 | Nonoperating Income Expense | -2502000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Notes Payable Current | 140000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001437749-25-016431 | 20240331 | Operating Expenses | 773000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Paid In Kind Interest | 98000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Payments To Acquire Intangible Assets | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Retained Earnings Accumulated Deficit | -451981000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Secured Long Term Debt | 42867000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Shares Outstanding | 88361000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20241231 | Stockholders Equity | 1140000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stockholders Equity | -451981000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Shares Share Based Compensation Gross | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Shares Share Based Compensation Gross | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Issued For Services | 93000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Issued For Services | 93000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | 0.0000 | USD | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Issued For Services | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 72000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 72000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20240331 | Net Cash Provided By Used In Investing Activities | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Accrued Salaries Current | 55000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Additional Paid In Capital | 400630000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 2560000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 4918000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Common Stock Shares Outstanding | 113970000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Convertible Debt Noncurrent | 225000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001437749-25-016431 | 20240331 | Depreciation Depletion And Amortization | 60000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Gain Loss Contingent Payment Obligation | -220000.0000 | USD | 1 | 0001437749-25-016431 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20240331 | Interest And Other Income | 23000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Liabilities And Stockholders Equity | 5879000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Repayments Of Long Term Debt | 34000.0000 | USD | 1 | us-gaap/2025 | Longterm Debt Type= Notes Payable Other Payables; | ||
| 0001437749-25-016431 | 20241231 | Retained Earnings Accumulated Deficit | -448182000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Revenues | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Selling General And Administrative Expense | 1243000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Share Based Compensation | 30000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20231231 | Shares Outstanding | 87681000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Comprehensive Income Net Of Tax | -3799000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Convertible Debt Current | 500000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Earnings Per Share Basic | -0.0100 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -605000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Interest And Other Income | 23000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-016431 | 20241231 | Liabilities Noncurrent | 49883000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Net Cash Provided By Used In Investing Activities | -34000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Net Income Loss | -3799000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Nonoperating Income Expense | 139000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Other Accrued Liabilities Current | 449000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Payments To Acquire Intangible Assets | 34000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Prepaid Expense Current | 217000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Share Based Compensation | 77000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Stockholders Equity | -49594000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Stockholders Equity | 1175000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 1401000.0000 | shares | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | 238000.0000 | USD | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20241231 | Unsecured Long Term Debt | 5935000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20231231 | Stockholders Equity | 393314000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Issued For Services | 18000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | 29000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 88164000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Depreciation Depletion And Amortization | 55000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 3280000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Common Stock Shares Issued | 117519000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Comprehensive Income Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20250331 | Convertible Debt Current | 1645000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001437749-25-016431 | 20241231 | Convertible Debt Noncurrent | 225000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants | 21000.0000 | USD | 1 | 0001437749-25-016431 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants | 0.0000 | USD | 1 | 0001437749-25-016431 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Net | -5000.0000 | USD | 1 | 0001437749-25-016431 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20250331 | Liabilities And Stockholders Equity | 4349000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Other Accrued Liabilities Current | 472000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Other Assets Current | 34000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights | -5000.0000 | USD | 1 | 0001437749-25-016431 | |||
| 0001437749-25-016431 | 20231231 | Stockholders Equity | 877000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20240331 | Stockholders Equity | -434403000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 92000.0000 | USD | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20250331 | Accounts Payable Current | 566000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Common Stock Value | 1140000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Comprehensive Income Net Of Tax | -693000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Comprehensive Income Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Comprehensive Income Net Of Tax | -3799000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20241231 | Accrued Professional Fees Current | 104000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Accrued Professional Fees Current | 71000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Assets | 5879000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Cash And Cash Equivalents At Carrying Value | 3280000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001437749-25-016431 | 20250331 | Convertible Debt Noncurrent | 1483000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001437749-25-016431 | 20250331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Intangible Assets Net Excluding Goodwill | 812000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Net | 0.0000 | USD | 1 | 0001437749-25-016431 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants Shares | 2148000.0000 | shares | 1 | 0001437749-25-016431 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20240331 | Net Cash Provided By Used In Operating Activities | -793000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Other Assets Noncurrent | 2000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Secured Long Term Debt | 40724000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Selling General And Administrative Expense | 773000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Stockholders Equity | -40023000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 560000.0000 | shares | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Shares Issued For Services | 120000.0000 | shares | 1 | us-gaap/2025 | Counterparty Name= Third Parties; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Shares Issued For Services | 120000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Shares Issued For Services | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Issued For Services | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20250331 | Additional Paid In Capital | 401212000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 2461000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -826000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Common Stock Shares Issued | 113970000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Comprehensive Income Net Of Tax | -693000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20250331 | Convertible Debt Current | 1645000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Gross Profit | -54000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -128000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Intangible Assets Net Excluding Goodwill | 832000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Interest And Other Income | 32000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants | 262000.0000 | USD | 1 | 0001437749-25-016431 | |||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Net | -5000.0000 | USD | 1 | 0001437749-25-016431 | |||
| 0001437749-25-016431 | 20250331 | Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Net | 0.0000 | USD | 1 | 0001437749-25-016431 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20241231 | Liabilities | 52291000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20241231 | Liabilities Current | 2408000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Liabilities Noncurrent | 50994000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Other Assets Current | 39000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20240331 | Revenues | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Shares Outstanding | 117519000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20231231 | Stockholders Equity | -433710000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-016431 | 20241231 | Stockholders Equity | -46412000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Stockholders Equity | 401212000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 98000.0000 | USD | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 6000.0000 | USD | 1 | us-gaap/2025 | Debt Conversion By Unique Description= Conversion And Payment Of Interestinkind On Convertible Debt; Equity Components= Common Stock; | ||
| 0001437749-25-016431 | 20240331 | Stock Issued During Period Value Issued For Services | 19000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-016431 | 20250331 | Unsecured Long Term Debt | 6253000.0000 | USD | 0 | us-gaap/2025 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Depreciation Depletion And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Convertible Debt Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Convertible Debt, Current | The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Other Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. |
| Payments To Acquire Intangible Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Intangible Assets | The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. |
| Selling General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Interest And Other Income | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). |
| Long Term Notes Payable | us-gaap/2025 | 0 | 0 | monetary | I | C | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Secured Long Term Debt | us-gaap/2025 | 0 | 0 | monetary | I | C | Secured Long-Term Debt, Noncurrent | Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets. |
| Unsecured Long Term Debt | us-gaap/2025 | 0 | 0 | monetary | I | C | Unsecured Long-Term Debt, Noncurrent | Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | us-gaap/2025 | 0 | 0 | monetary | D | D | Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) | Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2025 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Paid In Kind Interest | us-gaap/2025 | 0 | 0 | monetary | D | D | Paid-in-Kind Interest | Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method. |
| Comprehensive Income Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Stock Issued During Period Value Issued For Services | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Convertible Debt Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Convertible Debt, Noncurrent | Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock. |
| Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Shares | 0001437749-25-016431 | 1 | 0 | shares | D | Issuance of common stock and warrants in private offerings, net of issuance costs (in shares) | Represents net issuance of common stock upon exercise of options and warrants private in shares. | |
| Issuance Of Common Stock Upon Exercise Of Options And Warrants | 0001437749-25-016431 | 1 | 0 | monetary | D | C | Issuance of common stock upon exercise of options and warrants | Represents issuance of common stock upon exercise of options and warrants. |
| Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Net | 0001437749-25-016431 | 1 | 0 | monetary | D | C | Issuance of common stock and warrants in private offerings, net of issuance costs | Represents net issuance of common stock upon exercise of options and warrants private. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Stock Issued During Period Value Share Based Compensation Gross | us-gaap/2025 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture | Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Accrued Professional Fees Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Professional Fees, Current | Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Accrued Salaries Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Salaries, Current | Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Notes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Stock Issued During Period Shares Issued For Services | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Interest Expense Nonoperating | us-gaap/2025 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Repayments Of Long Term Debt | us-gaap/2025 | 0 | 0 | monetary | D | C | Repayments of Long-Term Debt | The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer. |
| Gain Loss Contingent Payment Obligation | 0001437749-25-016431 | 1 | 0 | monetary | D | C | Change in fair value of contingent payment obligations | Represents gain loss for contingent payment obligation. |
| Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights | 0001437749-25-016431 | 1 | 0 | monetary | D | D | Net payments from issuance of common stock and warrants in private offerings | Represents proceeds (payments) from issuance of common stock including contingent payment rights. |
| Prepaid Expense Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Proceeds From Warrant And Stock Option Exercised | 0001437749-25-016431 | 1 | 0 | monetary | D | D | Net proceeds from exercise of options and warrants | Cash inflow from warrant and stock option exercised. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Issuance Of Common Stock Upon Exercise Of Options And Warrants Shares | 0001437749-25-016431 | 1 | 0 | shares | D | Issuance of common stock upon exercise of options and warrants (in shares) | Represents issuance of common stock upon exercise of options and warrants in shares. | |
| Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Current | Amount of current assets classified as other. |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Shares Share Based Compensation Gross | us-gaap/2025 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture | Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). | |
| Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001437749-25-016431 | 2 | 8 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001437749-25-016431 | 2 | 9 | BS | 0 | H | Prepaid Expense Current | us-gaap/2025 | Prepaid expenses | 0 |
| 0001437749-25-016431 | 2 | 10 | BS | 0 | H | Other Assets Current | us-gaap/2025 | Other current assets | 0 |
| 0001437749-25-016431 | 2 | 11 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001437749-25-016431 | 2 | 12 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2025 | Intangible assets, net | 0 |
| 0001437749-25-016431 | 2 | 13 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other assets, net | 0 |
| 0001437749-25-016431 | 2 | 14 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001437749-25-016431 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001437749-25-016431 | 2 | 18 | BS | 0 | H | Accrued Salaries Current | us-gaap/2025 | Salaries and wages | 0 |
| 0001437749-25-016431 | 2 | 19 | BS | 0 | H | Accrued Professional Fees Current | us-gaap/2025 | Professional fees | 0 |
| 0001437749-25-016431 | 2 | 20 | BS | 0 | H | Other Accrued Liabilities Current | us-gaap/2025 | Other accrued expenses | 0 |
| 0001437749-25-016431 | 2 | 21 | BS | 0 | H | Notes Payable Current | us-gaap/2025 | Related party note payable, current portion | 0 |
| 0001437749-25-016431 | 2 | 22 | BS | 0 | H | Convertible Debt Current | us-gaap/2025 | Convertible notes, current portion | 0 |
| 0001437749-25-016431 | 2 | 23 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001437749-25-016431 | 2 | 25 | BS | 0 | H | Secured Long Term Debt | us-gaap/2025 | Secured contingent payment obligation | 0 |
| 0001437749-25-016431 | 2 | 26 | BS | 0 | H | Unsecured Long Term Debt | us-gaap/2025 | Unsecured contingent payment obligations | 0 |
| 0001437749-25-016431 | 2 | 27 | BS | 0 | H | Convertible Debt Noncurrent | us-gaap/2025 | Convertible notes, net of current portion | 0 |
| 0001437749-25-016431 | 2 | 28 | BS | 0 | H | Long Term Notes Payable | us-gaap/2025 | Related party note payable, net of current portion | 0 |
| 0001437749-25-016431 | 2 | 29 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2025 | Total long-term liabilities | 0 |
| 0001437749-25-016431 | 2 | 30 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001437749-25-016431 | 2 | 31 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | COMMITMENTS AND CONTINGENCIES | 0 |
| 0001437749-25-016431 | 2 | 33 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.01 par value, 225,000 shares authorized, 117,519 and 113,970 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001437749-25-016431 | 2 | 34 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001437749-25-016431 | 2 | 35 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001437749-25-016431 | 2 | 36 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total shareholders' deficit | 0 |
| 0001437749-25-016431 | 2 | 37 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and shareholders' deficit | 0 |
| 0001437749-25-016431 | 3 | 3 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in dollars per share) | 0 |
| 0001437749-25-016431 | 3 | 4 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized (in shares) | 0 |
| 0001437749-25-016431 | 3 | 5 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued (in shares) | 0 |
| 0001437749-25-016431 | 3 | 6 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding (in shares) | 0 |
| 0001437749-25-016431 | 4 | 3 | IS | 0 | H | Revenues | us-gaap/2025 | Revenue | 0 |
| 0001437749-25-016431 | 4 | 4 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | Cost of sales | 1 |
| 0001437749-25-016431 | 4 | 5 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross margin | 0 |
| 0001437749-25-016431 | 4 | 6 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2025 | Selling, general and administrative expenses | 0 |
| 0001437749-25-016431 | 4 | 7 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001437749-25-016431 | 4 | 8 | IS | 0 | H | Interest And Other Income | us-gaap/2025 | Interest income | 0 |
| 0001437749-25-016431 | 4 | 9 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2025 | Interest expense | 1 |
| 0001437749-25-016431 | 4 | 10 | IS | 0 | H | Gain Loss Contingent Payment Obligation | 0001437749-25-016431 | Change in fair value of contingent payment obligations | 0 |
| 0001437749-25-016431 | 4 | 11 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total interest and other | 0 |
| 0001437749-25-016431 | 4 | 12 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income taxes | 0 |
| 0001437749-25-016431 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001437749-25-016431 | 4 | 14 | IS | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2025 | Other comprehensive income, net of tax | 0 |
| 0001437749-25-016431 | 4 | 15 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Comprehensive loss | 0 |
| 0001437749-25-016431 | 4 | 16 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic and diluted net loss per common share (in dollars per share) | 0 |
| 0001437749-25-016431 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average common shares outstanding (in shares) | 0 |
| 0001437749-25-016431 | 5 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in shares) | 0 |
| 0001437749-25-016431 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001437749-25-016431 | 5 | 13 | EQ | 0 | H | Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Shares | 0001437749-25-016431 | Issuance of common stock and warrants in private offerings, net of issuance costs (in shares) | 0 |
| 0001437749-25-016431 | 5 | 14 | EQ | 0 | H | Issuance Of Common Stock Upon Exercise Of Options And Warrants Private Net | 0001437749-25-016431 | Issuance of common stock and warrants in private offerings, net of issuance costs | 0 |
| 0001437749-25-016431 | 5 | 15 | EQ | 0 | H | Issuance Of Common Stock Upon Exercise Of Options And Warrants Shares | 0001437749-25-016431 | Issuance of common stock upon exercise of options and warrants (in shares) | 0 |
| 0001437749-25-016431 | 5 | 16 | EQ | 0 | H | Issuance Of Common Stock Upon Exercise Of Options And Warrants | 0001437749-25-016431 | Issuance of common stock upon exercise of options and warrants | 0 |
| 0001437749-25-016431 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares Issued For Services | us-gaap/2025 | Issuance of equity-based instruments for services (in shares) | 0 |
| 0001437749-25-016431 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Issued For Services | us-gaap/2025 | Issuance of equity-based instruments for services | 0 |
| 0001437749-25-016431 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2025 | Issuance of common stock upon conversion and payment of interest-in-kind on convertible debt (in shares) | 0 |
| 0001437749-25-016431 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2025 | Issuance of common stock upon conversion and payment of interest-in-kind on convertible debt | 0 |
| 0001437749-25-016431 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation Gross | us-gaap/2025 | Share-based compensation (in shares) | 0 |
| 0001437749-25-016431 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation Gross | us-gaap/2025 | Share-based compensation | 0 |
| 0001437749-25-016431 | 5 | 23 | EQ | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Comprehensive loss for the period | 0 |
| 0001437749-25-016431 | 5 | 24 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in shares) | 0 |
| 0001437749-25-016431 | 5 | 25 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001437749-25-016431 | 6 | 7 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001437749-25-016431 | 6 | 9 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
| 0001437749-25-016431 | 6 | 10 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Share-based compensation | 0 |
| 0001437749-25-016431 | 6 | 11 | CF | 0 | H | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | us-gaap/2025 | Loss (gain) on changes in fair value of contingent payment obligations | 0 |
| 0001437749-25-016431 | 6 | 12 | CF | 0 | H | Paid In Kind Interest | us-gaap/2025 | Paid in kind interest expense | 0 |
| 0001437749-25-016431 | 6 | 14 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other assets | 1 |
| 0001437749-25-016431 | 6 | 15 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | Accounts payable and accrued expenses | 0 |
| 0001437749-25-016431 | 6 | 16 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001437749-25-016431 | 6 | 18 | CF | 0 | H | Payments To Acquire Intangible Assets | us-gaap/2025 | Capitalized patent costs | 1 |
| 0001437749-25-016431 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash used in investing activities | 0 |
| 0001437749-25-016431 | 6 | 21 | CF | 0 | H | Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights | 0001437749-25-016431 | Net payments from issuance of common stock and warrants in private offerings | 0 |
| 0001437749-25-016431 | 6 | 22 | CF | 0 | H | Proceeds From Warrant And Stock Option Exercised | 0001437749-25-016431 | Net proceeds from exercise of options and warrants | 0 |
| 0001437749-25-016431 | 6 | 23 | CF | 0 | H | Repayments Of Long Term Debt | us-gaap/2025 | Principal payments on long-term debt | 1 |
| 0001437749-25-016431 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by (used in) financing activities | 0 |
| 0001437749-25-016431 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | NET DECREASE IN CASH AND CASH EQUIVALENTS | 0 |
| 0001437749-25-016431 | 6 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | CASH AND CASH EQUIVALENTS, beginning of period | 0 |
| 0001437749-25-016431 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | CASH AND CASH EQUIVALENTS, end of period | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |